Radiomics Study of Thyroid Ultrasound for Predicting BRAF Mutation in Papillary Thyroid Carcinoma: Preliminary Results

References

1. 1.↵
   1. Davies L,
   2. Welch HG

   . Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 2006;295:2164–67 doi:10.1001/jama.295.18.2164 pmid:16684987

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Leenhardt L,
   2. Grosclaude P,
   3. Cherie-Challine L

   ; Thyroid Cancer Committee. Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 2004;14:1056–60 doi:10.1089/thy.2004.14.1056 pmid:15650358

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Xing M

   . BRAF mutation in thyroid cancer. Endocr Relat Cancer 2005;12:245–62 doi:10.1677/erc.1.0978 pmid:15947100

   Abstract/FREE Full Text
4. 4.↵
   1. Melck AL,
   2. Yip L,
   3. Carty SE

   . The utility of BRAF testing in the management of papillary thyroid cancer. Oncologist 2010;15:1285–93 doi:10.1634/theoncologist.2010-0156 pmid:21147872

   Abstract/FREE Full Text
5. 5.↵
   1. Kim KH,
   2. Kang DW,
   3. Kim SH, et al

   . Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population. Yonsei Med J 2004;45:818–21 doi:10.3349/ymj.2004.45.5.818 pmid:15515191

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Lee JH,
   2. Lee ES,
   3. Kim YS

   . Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis. Cancer 2007;110:38–46 doi:10.1002/cncr.22754 pmid:17520704

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Xing M,
   2. Westra WH,
   3. Tufano RP, et al

   . BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 2005;90:6373–79 doi:10.1210/jc.2005-0987 pmid:16174717

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Nikiforova MN,
   2. Kimura ET,
   3. Gandhi M, et al

   . BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 2003;88:5399–404 doi:10.1210/jc.2003-030838 pmid:14602780

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Kwak JY,
   2. Kim EK,
   3. Chung WY, et al

   . Association of BRAFV600E mutation with poor clinical prognostic factors and US features in Korean patients with papillary thyroid microcarcinoma. Radiology 2009;253:854–60 doi:10.1148/radiol.2533090471 pmid:19710001

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Haugen BR,
    2. Alexander EK,
    3. Bible KC, et al

    . 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016;26:1–133 doi:10.1089/thy.2015.0020 pmid:26462967

    CrossRefPubMed
11. 11.↵
    1. Kabaker AS,
    2. Tublin ME,
    3. Nikiforov YE, et al

    . Suspicious ultrasound characteristics predict BRAF V600E-positive papillary thyroid carcinoma. Thyroid 2012;22:585–89 doi:10.1089/thy.2011.0274 pmid:22524468

    CrossRefPubMed
12. 12.↵
    1. Hahn SY,
    2. Kim TH,
    3. Ki CS, et al

    . Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations. Oncotarget 2017;8:108946–57 doi:10.18632/oncotarget.22430 pmid:29312581

    CrossRefPubMed
13. 13.↵
    1. Hwang J,
    2. Shin JH,
    3. Han BK, et al

    . Papillary thyroid carcinoma with BRAFV600E mutation: sonographic prediction. AJR Am J Roentgenol 2010;194:W425–30 doi:10.2214/AJR.09.3512 pmid:20410389

    CrossRefPubMed
14. 14.↵
    1. Li Q,
    2. Yuan J,
    3. Wang Y, et al

    . Association between the BRAF V600E mutation and ultrasound features of the thyroid in thyroid papillary carcinoma. Oncol Lett 2017;14:1439–44 doi:10.3892/ol.2017.6276 pmid:28789361

    CrossRefPubMed
15. 15.↵
    1. Gillies RJ,
    2. Kinahan PE,
    3. Hricak H

    . Radiomics: images are more than pictures, they are data. Radiology 2016;278:563–77 doi:10.1148/radiol.2015151169 pmid:26579733

    CrossRefPubMed
16. 16.↵
    1. Kwon MR,
    2. Shin JH,
    3. Hahn SY, et al

    . Histogram analysis of greyscale sonograms to differentiate between the subtypes of follicular variant of papillary thyroid cancer. Clin Radiol 2018;73:591e1–e7 pmid:29459137, 29317047 pmid:29317047

    PubMed
17. 17.↵
    1. Song G,
    2. Xue F,
    3. Zhang C

    . A model using texture features to differentiate the nature of thyroid nodules on sonography. J Ultrasound Med 2015;34:1753–60 doi:10.7863/ultra.15.14.10045 pmid:26307120

    Abstract/FREE Full Text
18. 18.↵
    1. Chen SJ,
    2. Chang CY,
    3. Chang KY, et al

    . Classification of the thyroid nodules based on characteristic sonographic textural feature and correlated histopathology using hierarchical support vector machines. Ultrasound Med Biol 2010;36:2018–26 doi:10.1016/j.ultrasmedbio.2010.08.019 pmid:21092831

    CrossRefPubMed
19. 19.↵
    1. Nam SJ,
    2. Yoo J,
    3. Lee HS, et al

    . Quantitative evaluation for differentiating malignant and benign thyroid nodules using histogram analysis of grayscale sonograms. J Ultrasound Med 2016;35:775–82 doi:10.7863/ultra.15.05055 pmid:26969596

    Abstract/FREE Full Text
20. 20.↵
    1. Grani G,
    2. D’Alessandri M,
    3. Carbotta G, et al

    . Grey-scale analysis improves the ultrasonographic evaluation of thyroid nodules. Medicine (Baltimore) 2015;94:e1129 doi:10.1097/MD.0000000000001129 pmid:26166117

    CrossRefPubMed
21. 21.↵
    1. Bhatia KS,
    2. Lam AC,
    3. Pang SW, et al

    . Feasibility study of texture analysis using ultrasound shear wave elastography to predict malignancy in thyroid nodules. Ultrasound Med Biol 2016;42:1671–80 doi:10.1016/j.ultrasmedbio.2016.01.013 pmid:27126245

    CrossRefPubMed
22. 22.↵
    1. Shin JH,
    2. Baek JH,
    3. Chung J, et al

    ; Korean Society of Thyroid Radiology (KSThR) and Korean Society of Radiology. Ultrasonography diagnosis and imaging-based management of thyroid nodules: revised Korean Society of Thyroid Radiology consensus statement and recommendations. Korean J Radiol 2016;17:370–95 doi:10.3348/kjr.2016.17.3.370 pmid:27134526

    CrossRefPubMed
23. 23.↵
    1. Tessler FN,
    2. Middleton WD,
    3. Grant EG, et al

    . ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol 2017;14:587–95 doi:10.1016/j.jacr.2017.01.046 pmid:28372962

    CrossRefPubMed
24. 24.↵
    1. van Griethuysen JJ,
    2. Fedorov A,
    3. Parmar C, et al

    . Computational radiomics system to decode the radiographic phenotype. Cancer Res 2017;77:e104-07 doi:10.1158/0008-5472.CAN-17-0339 pmid:29092951

    CrossRefPubMed
25. 25.↵
    1. Peng H,
    2. Long F,
    3. Ding C

    . Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy. IEEE Trans Pattern Anal Mach Intell 2005;27:1226–23 doi:10.1109/TPAMI.2005.159 pmid:16119262

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Yang L,
    2. Dong D,
    3. Fang M, et al

    . Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer? Eur Radio 2018;28:2058–67 doi:10.1007/s00330-017-5146-8 pmid:29335867

    CrossRefPubMed
27. 27.↵
    1. Liu Y,
    2. Kim J,
    3. Balagurunathan Y, et al

    . Radiomic features are associated with EGFR mutation status in lung adenocarcinomas. Clin Lung Cancer 2016;17:441–48e6 doi:10.1016/j.cllc.2016.02.001 pmid:27017476

    CrossRefPubMed
28. 28.↵
    1. Li H,
    2. Zhu Y,
    3. Burnside ES, et al

    . MR imaging radiomics signatures for predicting the risk of breast cancer recurrence as given by research versions of MammaPrint, Oncotype DX, and PAM50 gene assays. Radiology 2016;281:382–91 doi:10.1148/radiol.2016152110 pmid:27144536

    CrossRefPubMed
29. 29.↵
    1. Chen X,
    2. Tong Y,
    3. Shi Z, et al

    . Noninvasive molecular diagnosis of craniopharyngioma with MRI-based radiomics approach. BMC Neurol 2019;19:6 doi:10.1186/s12883-018-1216-z pmid:30616515

    CrossRefPubMed
30. 30.↵
    1. Lee SE,
    2. Han K,
    3. Kwak JY, et al

    . Radiomics of US texture features in differential diagnosis between triple-negative breast cancer and fibroadenoma. Sci Rep 2018;8:13546 doi:10.1038/s41598-018-31906-4 pmid:30202040

    CrossRefPubMed
31. 31.↵
    1. Breiman L

    . Random forests. Machine Learning 2001;45:5–32 doi:10.1023/A:1010933404324

    CrossRef
32. 32.↵
    1. Guerra A,
    2. Sapio MR,
    3. Marotta V, et al

    . The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma. J Clin Endocrinol Metab 2012;97:517–24 doi:10.1210/jc.2011-0618 pmid:22170714

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Guerra A,
    2. Fugazzola L,
    3. Marotta V, et al

    . A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome. J Clin Endocrinol Metab 2012;97:2333–40 doi:10.1210/jc.2011-3106 pmid:22508706

    CrossRefPubMedWeb of Science